Floreane Medical strategy yields budget-beating rise
This article was originally published in Clinica
Executive Summary
French medical implants company Floreane (Trevoux) beat its own fourth quarter and full year 2003-04 sales targets, achieving Euros7m ($8.8m) and Euros22.9m, respectively. Final quarter sales were 16.7% up on the previous year (+19.7% with constant exchange rates), while the full year figure was 21.5% ahead of the 2002-03 total, beating the Euronext-quoted company's own year-end projection by 1.5%.